Former Cy Young winner takes powerful drug to aid his performance, no one cares

57 Comments

What if I were to tell you that there was a former Cy Young winner who was taking a controversial and powerful drug?

A drug that could prove dangerous to him in the long run and has been linked to organ damage? A drug that other players who have used it say gives them a feeling of invulnerability? A drug that experts are wary of for athletes because its long term effects when taken regularly aren’t known? A drug that is injected into the buttocks. A drug that, despite all of this, the player uses because it helps him recover from injury, soreness and fatigue and helps him get back on the field?

Why, I hope you would say nothing, because as David Lennon of Newsday reports, it’s totally OK in Major League Baseball:

When Johan Santana said last week that he received an injection of Toradol, a powerful anti-inflammatory medication, to stay on schedule for his Opening Day start, it hardly raised eyebrows in the clubhouse.

The reason? Santana is not the only one to benefit from the drug, and its use is more common than people might think.

There is not some logical bright line between what is a horrible, terrible PED and what is an acceptable drug in the world of sports. We like to pretend there is, but really, there isn’t. The biggest difference is that some are on a banned list and some are not, and that Santana and others use Toradol under a physicians care and guys who take banned drugs don’t.

Ultimately, these drugs are allowing players to do what their body would not naturally allow them to do. Here, it’s ignoring pain that could keep them from playing or certainly playing well.  With other drugs, it’s recovering from injury faster (HGH) or hitting a ball farther than they otherwise might (steroids). Either way, their performance is enhanced. Their natural state is altered by pharmaceuticals.

It would be awesome if we could approach some of the banned PEDs in this way and determine whether they present acceptable risks. Whether they serve a valuable purpose that, under a doctor’s care, don’t raise serious ethical concerns.  But we just don’t roll that way in professional sports these days.

Report: Adam Eaton to miss rest of the season with a torn ACL

Getty Images
1 Comment

It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 4-3 win over the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:

The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.

Shelby Miller will undergo Tommy John surgery

Getty Images
1 Comment

Last we heard from Shelby Miller, the Diamondbacks’ right-hander was contemplating Tommy John surgery for a partial UCL tear in his right elbow. Now, he appears to have decided to go through with the procedure.

Miller decided to skip Tommy John alternatives like plasma-rich platelet injections or stem cell treatment, which have been used to varying degrees of success by other major league pitchers with similar injuries. The surgery will set him back an estimated 12-18 months, FanRag Sports’ Tommy Stokke reports, which puts Miller’s estimated return date somewhere in 2018 if all goes well.

The 26-year-old starter was off to a rocky start this season, posting a 2-2 record and 4.09 ERA through 22 innings and striking out just 20 of 99 batters faced. This was his sophomore campaign in Arizona after muddling through the 2016 season with a 3-12 record, 6.15 ERA and 0.5 fWAR over 101 innings with the club.